Bone MarrowPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationBone Marrow CellsHematopoietic Stem Cell TransplantationStem CellsTransplantation, AutologousHematopoietic Stem CellsTransplantation, HomologousHematopoietic Stem Cell MobilizationGraft SurvivalKidney TransplantationGranulocyte Colony-Stimulating FactorCord Blood Stem Cell TransplantationGraft vs Host DiseaseAntigens, CD34LeukapheresisStem Cell TransplantationTissue DonorsTransplantation ConditioningBone Marrow DiseasesTransplantsImmunosuppressive AgentsHematologic NeoplasmsBlood Component RemovalGraft RejectionHematopoiesisTreatment OutcomeBone Marrow PurgingMelphalanCyclophosphamideBone Marrow ExaminationCombined Modality TherapyWhole-Body IrradiationTime FactorsColony-Forming Units AssayMultiple MyelomaPlant StemsBusulfanHistocompatibility TestingBlood CellsHeart TransplantationLeukemiaBone Marrow NeoplasmsHistocompatibilityTransplantation ChimeraNeoplastic Stem CellsRecurrenceRetrospective StudiesAdult Stem CellsTransplantationBlood Cell CountAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsFetal BloodCyclosporineImmunosuppressionLung TransplantationCell DifferentiationCells, CulturedLymphoma, Non-HodgkinMice, Inbred C57BLCytomegalovirus InfectionsFlow CytometryStem Cell FactorTransplantation, IsogeneicCell SeparationPluripotent Stem CellsLeukemia, Myeloid, AcuteStem Cell NicheSurvival RateCell LineageSurvival AnalysisTacrolimusRemission InductionTransplantation ImmunologyEtoposideInfectionMesenchymal Stem Cell TransplantationAntineoplastic Agents, AlkylatingTissue and Organ ProcurementFollow-Up StudiesMyeloablative AgonistsThiotepaNeural Stem CellsMyelodysplastic SyndromesHematologic DiseasesImmunophenotypingMultipotent Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositivePlatelet CountGranulocytesLeukocyte CountDisease-Free SurvivalAntigens, CDAcute DiseaseImmunocompromised HostInduced Pluripotent Stem CellsLiving DonorsLymphoma